Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
adjuvant
Biotech
CureVac rethinks lead cancer program after posting PD-1 data
CureVac has vowed to only consider further clinical studies if the drug candidate is paired with “a defined mRNA cancer vaccine.”
Nick Paul Taylor
Nov 16, 2022 8:30am
Novavax BA.1 booster data support COVID-19 vaccine strain switch
Nov 8, 2022 9:40am
Clover's COVID-19 vaccine tames delta in pivotal study
Sep 22, 2021 8:55am
Sanofi nets global phase 3 partners for breast cancer hopeful
Jun 4, 2021 1:00am
Medicago, GSK post data on plant-derived COVID-19 vaccine
May 18, 2021 5:21am
Clover nears pivotal trial of GSK-adjuvanted COVID-19 vaccine
Dec 4, 2020 8:25am